Pathological circuit function is at the origin of many symptoms of neurological disorders. The optogenetic toolbox applied to animal models of behavioral diseases has in the last years led to decisive progress with the hope that deep brain stimulation (DBS) may be used for rational treatments.
OptoDBS 2019 will discuss the state of the art of current therapies for DBS and ask how a better understanding of neural circuit dysfunction in pathology could inspire novel protocols. A particular emphasis will be on novel DBS indications such as obsessive compulsive disorders (OCD), depression or addiction. The meeting will take place from June 20 to 22, 2019, at the Campus Biotech in Geneva.